Reversible Changes in Brain Glucose Metabolism Following Thyroid Function Normalization in Hyperthyroidism

References

1. 1.↵
   1. Fahrenfort JJ,
   2. Wilterdink AM,
   3. van der Veen EA

   . Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 2000; 25: 201– 11

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Sait Gonen M,
   2. Kisakol G,
   3. Savas Cilli A,
   4. et al

   . Assessment of anxiety in subclinical thyroid disorders. Endocr J 2004; 51: 311– 15

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Bauer M,
   2. Szuba MP,
   3. Whybrow PC

   , eds. Psychiatric and Behavioral Manifestations of Hyper- and Hypothyroidism. Washington, DC: American Psychiatric Press; 2003
4. 4.↵
   1. Schreckenberger MF,
   2. Egle UT,
   3. Drecker S,
   4. et al

   . Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab 2006; 91: 4786– 91

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Zung WW

   . A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371– 79

   PubMedWeb of Science
6. 6.↵
   1. Zung WW

   . A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63– 70

   CrossRefPubMedWeb of Science
7. 7.↵
   American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 2000
8. 8.↵
   1. Zung WW

   . From art to science: the diagnosis and treatment of depression. Arch Gen Psychiatry 1973; 29: 328– 37

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Zung WW

   , ed. How Normal is Anxiety? Current Concepts. Durham, North Carolina: Upjohn; 1980
10. 10.↵
    1. Sharpley CF,
    2. Christie DR

    . An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer. Psychooncology 2007; 16: 660– 67

    CrossRefPubMed
11. 11.↵
    1. Sharpley CF BV,
    2. Christie DR

    . Understanding the causes of depression among prostate cancer patients: development of the Effects of Prostate Cancer on Lifestyle Questionnaire. Psychooncology 2009; 18: 162– 68

    CrossRefPubMed
12. 12.↵
    1. Schaefer A,
    2. Brown J,
    3. Watson CG,
    4. et al

    . Comparison of the validities of the Beck, Zung, and MMPI Depression Scales. J Consult Clin Psychol 1985; 53: 415– 18

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Wang J,
    2. Ma Y,
    3. Huang Z,
    4. et al

    . Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. J Neurol 2009; 257: 72– 78

    PubMed
14. 14.↵
    1. Saxena S,
    2. Brody AL,
    3. Ho ML,
    4. et al

    . Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003; 160: 522– 32

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Smith GS,
    2. Kramer E,
    3. Hermann C,
    4. et al

    . Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biol Psychiatry 2009; 66: 259– 66

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Lancaster JL,
    2. Woldorff MG,
    3. Parsons LM,
    4. et al

    . Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000; 10: 120– 31

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Huang C,
    2. Tang C,
    3. Feigin A,
    4. et al

    . Changes in network activity with the progression of Parkinson's disease. Brain 2007; 130: 1834– 46

    Abstract/FREE Full Text
18. 18.↵
    1. Bhatara VS,
    2. Tripathi RP,
    3. Sankar R,
    4. et al

    . Frontal lobe proton magnetic-resonance spectroscopy in Graves' disease: a pilot study. Psychoneuroendocrinology 1998; 23: 605– 12

    CrossRefPubMed
19. 19.↵
    1. Drevets WC

    . Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813–29

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Rosen HJ,
    2. Levenson RW

    . The emotional brain: combining insights from patients and basic science. Neurocase 2009; 15: 173– 81

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Sokoloff L,
    2. Wechsler RL,
    3. Mangold R,
    4. et al

    . Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment. J Clin Invest 1953; 32: 202– 08

    PubMedWeb of Science
22. 22.↵
    1. Sensenbach W,
    2. Madison L,
    3. Eisenberg S,
    4. Ochs L

    . The cerebral circulation and metabolism in hyperthyroidism and myxedema. J Clin Invest 1954; 33: 1434– 40

    CrossRefPubMed
23. 23.↵
    1. Fukui T,
    2. Hasegawa Y,
    3. Takenaka H

    . Hyperthyroid dementia: clinicoradiological findings and response to treatment. J Neurol Sci 2001; 184: 81– 88

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Davidson RJ,
    2. Lewis DA,
    3. Alloy LB,
    4. et al

    . Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 2002; 52: 478– 502

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Bauer M,
    2. Silverman DH,
    3. Schlagenhauf F,
    4. et al

    . Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab 2009; 94: 2922– 29

    CrossRefPubMed
26. 26.↵
    1. Marangell LB,
    2. Ketter TA,
    3. George MS,
    4. et al

    . Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry 1997; 154: 224– 30

    PubMedWeb of Science
27. 27.↵
    1. Bench CJ,
    2. Friston KJ,
    3. Brown RG,
    4. et al

    . Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23: 579– 90

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Mayberg H

    . Depression. II. Localization of pathophysiology. Am J Psychiatry 2002; 159: 1979

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Wilcoxon JS,
    2. Nadolski GJ,
    3. Samarut J,
    4. et al

    . Behavioral inhibition and impaired spatial learning and memory in hypothyroid mice lacking thyroid hormone receptor alpha. Behav Brain Res 2007; 177: 109– 16

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Mooradian AD,
    2. Girgis W,
    3. Shah GN

    . Thyroid hormone-induced GLUT-1 expression in rat cerebral tissue: effect of age. Brain Res 1997; 747: 144– 46

    CrossRefPubMed
31. 31.↵
    1. Lass P,
    2. Slawek J,
    3. Derejko M,
    4. et al

    . Neurological and psychiatric disorders in thyroid dysfunctions: the role of nuclear medicine—SPECT and PET imaging. Minerva Endocrinol 2008; 33: 75– 84

    PubMedWeb of Science